The TNM classification of malignant tumours-towards common understanding and reasonable expectations

Affiliations

¹ Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON, M5G 2M9, Canada.
² Department of Surgery, University of Washington, Seattle, WA, USA.
³ University Institute of Pathology, Lausanne University Medical Center, Lausanne, Switzerland.
⁴ Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
⁵ Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
⁶ Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France.
⁷ Belgium Cancer Registry, Brussels, Belgium.
⁸ Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
⁹ Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON, M5G 2M9, Canada. Electronic address: marykg@rmp.uhn.on.ca.

Brian O'Sullivan et al. Lancet Oncol. 2017 Jul.

. 2017 Jul;18(7):849-851.

doi: 10.1016/S1470-2045(17)30438-2.

¹ Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON, M5G 2M9, Canada.
² Department of Surgery, University of Washington, Seattle, WA, USA.
³ University Institute of Pathology, Lausanne University Medical Center, Lausanne, Switzerland.
⁴ Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
⁵ Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
⁶ Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France.
⁷ Belgium Cancer Registry, Brussels, Belgium.
⁸ Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
⁹ Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON, M5G 2M9, Canada. Electronic address: marykg@rmp.uhn.on.ca.

No abstract available

Conflict of interest statement

We declare no competing interests.

1. Brierley JD, Gospodarowicz MK, Wittekind C, editors. The TNM classification of malignant tumours. 8. Oxford: Wiley Blackwell; 2017.
1. Amin MB, Edge S, Greene F, et al., editors. AJCC cancer staging manual. 8. New York: Springer; 2017.
1. Brierley JD, Srigley JR, Yurcan M, et al. The value of collecting population-based cancer stage data to support decision-making at organizational, regional and population levels. Healthc Q. 2013;16:27–33. - PubMed
1. Piñeros M, Znaor A, Mery L, Bray F. A global cancer surveillance framework within noncommunicable disease surveillance: making the case for population-based cancer registries. Epidemiol Rev. 2017;39:161–69. - PubMed
1. O’Sullivan B, Brierley JD, Gospodarowicz MK. Prognosis and classification of cancer. In: O’Sullivan B, editor. Manual of clinical oncology. Oxford: John Wiley and Sons; 2015.